Interventional Oncology & Embolization
Boston Scientific’s Interventional Oncology & Embolization grant supports research and access to minimally invasive cancer therapies for underserved and humanitarian patient populations.
Funder: Boston Scientific
Due Dates: August 17, 2026 | September 14, 2026 | October 12, 2026 | November 4, 2026 | December 1, 2026
Funding Amounts: Product donations for eligible projects and humanitarian missions; cash awards not specified.
Summary: Supports access to minimally invasive cancer care by providing product donations and innovative therapies for indigent care and humanitarian missions.
Description
Boston Scientific’s Interventional Oncology & Embolization initiative aims to improve patient outcomes in oncology through access to minimally invasive cancer treatments. This program supports physicians, healthcare institutions, and humanitarian missions by providing product donations—most notably TheraSphere™ Y-90 Glass Microspheres—for indigent care and global humanitarian efforts. The initiative focuses on advancing the reach of clinically advanced, transformational cancer therapies to underserved populations.
